 |
Malaria Vaccine ELISA and Reagents
RTS,S ELISAs: Assess vaccine efficacy, measure IgG subclasses, and IgM. |
 .....Read More. |
| Malaria Vaccine ELISA and Reagents | ||||||
| Catalog Number | Product Description | Product Type | Size | |||
| 970-300-SMG | Monkey (simian) Anti-Malaria IgG ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-320-MSG | Mouse Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgG ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-330-MSM | Mouse Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgM ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-340-RMG | Rabbit Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgG ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-350-RMM | Rabbit Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgM ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-360-HMG | Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgG ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-370-HMM | Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgM ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-500-SMG | Monkey (simian) Anti-Malaria IgG ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-200-CSR | Rabbit Anti-Circumsporozoite protein (CSP, P falciparum/RTS,S vaccine) IgG ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-210-CSM | Rabbit Anti-Circumsporozoite protein (CSP, P falciparum/RTS,S vaccine) IgM ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-300-MMG | Mouse Anti-Circumsporozoite protein (CSP, P falciparum/RTS,S vaccine) IgG ELISA kit ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-310-MMM | Mouse Anti-Circumsporozoite protein (CSP, P falciparum/RTS,S vaccine) IgM ELISA kit ELISA kit | ELISA Kit | 1 Kit | |||
| 970-400-CHG | Human Anti-Circumsporozoite protein (CSP, P falciparum/RTS,S vaccine) IgG ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-410-CHM | Human Anti-Circumsporozoite protein (CSP, P falciparum/RTS,S vaccine) IgM ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 970-100-MMG | Mouse Anti-Circumsporozoite protein (CSP, P falciparum) IgG ELISA kit ELISA kit, 2x96 tests | ELISA Kit | 1 pk | |||
| 970-110-MMM | Mouse Anti-Circumsporozoite protein (CSP, P falciparum) IgM ELISA kit ELISA kit | ELISA Kit | 1 pk | |||
| CSPF11-S | Anti-Circumsporozoite (CSP, P.falciparum) C-terminal (207-397 aa) His-tag protein antiserum | Antibodies | 100 ul | |||
| CSPV11-M | Mouse Anti-Circumsporozoite (CSP) (P. vivax) IgG, aff pure #1 | Antibodies | 100 ug | |||
| CSPV12-M | Mouse Anti-Circumsporozoite (CSP) (P. vivax) IgG, aff pure #2 | Antibodies | 100 ug | |||
| DRAA31-A | Anti-(DRAAGQPAG)3 peptide (repeat-sequence peptide of the P. vivax circumsporozoite protein, CSP) IgG, aff pure | Antibodies | 100 ul | |||
| NANP51-A | Anti-(NANP)5 peptide (25-aa, repeat-sequence peptide of the P. falciparum circumsporozoite protein), CSP IgG, aff pure | Antibodies | 100 ul | |||
| NVDP41-A | Anti-(NVDP)4 peptide (minor repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) IgG, aff pure | Antibodies | 100 ul | |||
| PPPP321-A | Anti-(PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) IgG, aff pure | Antibodies | 100 ul | |||
| 970-360-01N | Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgG antiserum negative control | antiserum | 1 ml | |||
| 970-360-02P | Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgG antiserum positive control | antiserum | 1 ml | |||
| 970-370-01N | Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgM antiserum negative control | antiserum | 1 ml | |||
| 970-370-02P | Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgM antiserum positive control | antiserum | 1 ml | |||
| HBG25-P | DABCYL-GABA-ERMFLSFP-EDANS, Hemoglobin, 3037a, Malaria FRET Substrate II | Substrates | 1 mg | |||
| HBG31-P | DABCYL-GABA-ALERMFLSFP-EDANS, Hemoglobin, 2837a, Malaria FRET Substrate III | Substrates | 1 mg | |||
| MAPF15-P | DABCYL-ERNleFLSFP-EDANS, Malaria Aspartyl Proteinase FRET (Fluorescence Resonance Energy Transfer) Substrate I | Substrates | 1 mg | |||
| MAPF15-P-5 | DABCYL-ERNleFLSFP-EDANS, Malaria Aspartyl Proteinase FRET Substrate I | Substrates | 5 mg | |||
| RP-649 | duplicate item same as HSPF701-R; Recombinant Malaria Protein HSP | Pure protein | 100 ug | |||
| RP-650 | duplicate item same as CSPF16-R; same Recombinant Malaria Cs Mosaic | Pure protein | 100 ug | |||
| SP-88358-1 | MSP-1 P2, Malaria Merozoite Surface Peptide ? 1 (AA: Gly-Tyr-Arg-Lys-Pro-Leu-Asp-Asn-Ile-Lys-Asp-Asn-Val-Gly-Lys-Met-Glu-Asp-Tyr-Ile-Lys-Lys) (MW: 2625.07) | Pure Peptide | 1 mg | |||
| SP-54352-1 | CSP (AA: Glu-Met-Arg-Leu-Ser-Lys-Phe-Phe-Arg-Asp-Phe-Ile-Leu-Gln-Arg-Lys-Lys) (MW: 2242.74) | Pure Peptide | 1 mg | |||
| CSPY11-P | KIYNRNIVNRLLGD, P. yoelii circumsporozoite protein (57?70), PyCSP (57?70) peptide | Peptides pure | 1 mg | |||
| CSPY12-P | SYVPSAEQI,P. yoelii circumsporozoite protein (280?288), PyCSP (280?288) peptide | Peptides pure | 1 mg | |||
| CSPF15-P | YLKKIKNSL, P. falciparum circumsporozoite (CSP 334-342) polypeptide | Peptides pure | 1 mg | |||
| DRAA31-P | (DRAAGQPAG)3 (repeat-sequence peptide of the P. vivax circumsporozoite protein, CSP) control/blocking peptide | Peptides pure | 100 ug | |||
| DRAD31-P | (DRADGQPAG)3 peptide (repeat-sequence peptide of the P. vivax circumsporozoite protein, CSP), pure | Peptides pure | 1 mg | |||
| NANP101-P | (NANP)10 (40-aa NANP repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) peptide, pure | Peptides pure | 0.5 mg | |||
| NANP51-P | (NANP)5 peptide (repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide | Peptides pure | 1 mg | |||
| NVDP41-P | (NVDP)4 peptide (minor repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide | Peptides pure | 100 ug | |||
| PAPP311-P | (PAPPNAAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP), pure | Peptides pure | 1 mg | |||
| PPPP312-P | (PPPPNPPND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP), pure | Peptides pure | 1 mg | |||
| PPPP321-P | (PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) control/blocking peptide | Peptides pure | 100 ug | |||
| RP-650 | duplicate item same as CSPF16-R; same Recombinant Malaria Cs Mosaic | Pure protein | 100 ug | |||
| CSPF11-C | Recombinant purified Circumsporozoite (CSP, P.falciparum) C-terminal (207-397 aa) His-tag protein control for Western | Protein control | 100 ul | |||
| CSPF15-R-10 | Recombinant (P. fluorescens) Circumsporozoite protein (P. falciparum, CSP 21-382aa, full length, ~39 kda, >95%), Low Endotoxin | 10 ug | ||||
| CSPF17-R-100 | Recombinant (E. coli), purified, Circumsporozoite (CSP) C-terminal (207-397 aa) His-tag protein, P.falciparum) | Recomb. Protein | 100 ug | |||
| CSPV11-C | Recombinant Circumsporozoite (CSP; 353-aa and GST) protein control for Western blot | Recomb. Protein | 100 ul | |||
| CSPV16-R | Recombinant (E. coli) Circumsporozoite (CSP; 353-aa and GST) antigen (P. vivax) | Recomb. Protein | 100 ug | |||
| PPPP321-BSA | (PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) conjugated with BSA | Conjugated Peptides | 0.5 mg | |||
| DRAA31-BSA | (DRAAGQPAG)3 peptide (repeat-sequence peptide of the P. vivax circumsporozoite protein, CSP) conjugated with BSA | Conjugated Peptides | 0.5 mg | |||
| NANP51-BSA | (NANP)5 peptide (25-aa, repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) conjugated with BSA | Conjugated Peptides | 0.5 mg | |||
| NVDP41-BSA | (NVDP)4 peptide (minor repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) conjugated with BSA | Conjugated Peptides | 0.5 mg | |||
| 970-510-DBG | Human Anti-Duffy Binding like5 (DBL5/VAR2CSA) Domain IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 970-515-DBM | Human Anti-Duffy Binding like5 (DBL5/VAR2CSA) Domain IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 970-520-DBG | Mouse Anti-Duffy Binding like5 (DBL5/VAR2CSA) Domain IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 970-525-DBM | Mouse Anti-Duffy Binding like5 (DBL5/VAR2CSA) Domain IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 970-540-DBG | Monkey Anti-Duffy Binding like5 (DBL5/VAR2CSA) Domain IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 970-545-DBM | Monkey Anti-Duffy Binding like5 (DBL5/VAR2CSA) Domain IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| DBL51-A | Rabbit Anti-Duffy Binding like5 (DBL5/VAR2CSA) Domain protein IgG | Antibodies | 100 ul | |||
| DBL51-C | Recombinant Duffy Binding like5 (DBL5/VAR2CSA) Domain protein (45 kda) control for Western | Western control | 100 ul | |||
| DBL55-R-10 | Recombinant (E. coli) Duffy Binding like5 (DBL5/VAR2CSA) Domain protein for ELISA/Western (>95%, ~45 kda, his-tag) | Rec. Protein | 10 ug | |||
| 970-100-MMG | Mouse Anti-Circumsporozoite protein (CSP, P falciparum) IgG ELISA kit ELISA kit, 2x96 tests | 1 pk | 1 pk | |||
| 970-600-CHG | Human Anti-Chagas/Trypanosoma cruzi IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | ||||
| DBL51-S | Anti- VAR2CSA membrane (1981-2336 aa) C-terminal His-tag protein (P. falciparum) | Antiserum | 100 ul | |||
| HRPF21-M | Mouse Anti-Histidine rich glycoprotein II (HRP II, P. falciparum) IgG clone #1 | Antibodies | 100 ug | |||
| HRPF22-M | Mouse Anti-Histidine rich glycoprotein II (HRP II, P. falciparum) IgG clone 32 | Antibodies | 100 ug | |||
| HRPF25-R | Recombinant (E. coli) Histidine rich glycoprotein II (HRP II, P. falciparum) | Recomb. Protein | 100 ug | |||
| LSPF31-P | LEESQVNDDIFNSLVKSVQQEQQHNV, P. falciparum Liver-Stage Antigen 3-NRII, LSA3-NRII (81-106) peptide | Peptides pure | 1 mg | |||
| LSPF32-P | DELFNELLNSVDVNGENILEESQ, P. falciparum Liver-Stage Antigen 3-NRI (LSA3-NRI) peptide | Peptides pure | 1 mg | |||
| MSPF11-M | Mouse Anti-Merozoite surface protein-1 (MSP-1; P. falciparum) IgG, aff pure #1 | Antibodies | 100 ug | |||
| MSPF11-P | VTHESYQELVKKLEALEDAV, MSP-1 P1, peptide of P. falciparum Merozoite Surface Protein 1 | Peptides pure | 1 mg | |||
| MSPF12-M | Mouse Anti-Merozoite surface protein-1 (MSP-1; P. falciparum) IgG, aff pure #2 | Antibodies | 100 ug | |||
| MSPF12-P | GYRKPLDNIKDNVGKMEDYIKK, MSP-1 P2, peptide of P. falciparum Merozoite Surface Protein 1 | Peptides pure | 1 mg | |||
| MSPF131-P | KLNSLNNPHNVLQNFSVFFNK, MSP-1 P3, peptide of P. falciparum Merozoite Surface Protein 1 | Peptides pure | 1 mg | |||
| MSPF131P | KLNSLNNPHNVLQNFSVFFNK, MSP-1 P3, peptide of P. falciparum Merozoite Surface Protein 1 | Peptides pure | 1 mg | |||
| MSPF14-S | Anti-Merozoite surface protein-1 (MSP-1; P. falciparum) antierum | Antiserum | 100 ul | |||
| MSPF15-R | Recombinant (E. coli) merozoite surface protein-1 (MSP-1; P. falciparum) | Recomb. Protein | 100 ug | |||
| MSPF21-S | Anti-Merozoite surface protein-2 (MSP-2; P. falciparum) antierum | Antiserum | 100 ul | |||
| MSPF25-R | Recombinant (E. coli) merozoite surface protein-2 (MSP-2; P. falciparum) | Recomb. Protein | 100 ug | |||
| MSPV11-P | LEYYLREKAKMAGTLIIPES, P. vivax PvMSP-1 peptide 19 (378-397) | Peptides pure | 1 mg | |||
| MSPV12-P | SKDQIKKLTSLKNKLERRQN, P. vivax PvMSP-1 peptide 53 (1058-1077) | Peptides pure | 1 mg | |||
| MSPV13-P | NFVGKFLELQIPGHTDLLHL, P. vivax PvMSP-1 peptide 4 (78-97) | Peptides pure | 1 mg | |||
| MSPV14-M | Mouse Anti-Merozoite surface protein-1 (MSP-1; P. vivax) IgG, aff pure #1 | Antibodies | 100 ug | |||
| MSPV14-P | FNQLMHVINFHYDLLRANVH, P. vivax PvMSP-1 peptide 6 (118-137) | Peptides pure | 1 mg | |||
| MSPV15-P | LDMLKKVVLGLWKPLDNIKD, P. vivax PvMSP-1 peptide 8 (158-177) | Peptides pure | 1 mg | |||
| MSPV16-R | Recombinant (E. coli) merozoite surface protein-1 (MSP-1; 108-aa; P. vivax) | Recomb. Protein | 100 ug | |||
| MSPV26-R | Recombinant (E. coli) merozoite surface protein-2 (MSP-2; 460-aa; P. vivax) | Recomb. Protein | 100 ug | |||
| PLDH09-M | Mouse Anti-parasite specific lactate dehydrogenase (pLDH), (PAN PLDH), clone 9 | Antibodies | 100 ug | |||
| PLDH14-M | Mouse Anti-parasite specific lactate dehydrogenase (pLDH), (P. ovale specific), clone 14 | Antibodies | 100 ug | |||
| PLDH21-M | Mouse Anti-parasite lactate dehydrogenase (pan-pLDH), clone 1 | Antibodies | 100 ug | |||
| PLDH22-M | Mouse Anti-parasite specific lactate dehydrogenase (pLDH), (P. falciparum specific), clone 2 | Antibodies | 100 ug | |||
| PLDH31-M | Mouse Anti-parasite specific lactate dehydrogenase (pLDH), (P. vivax specific), clone 3 | Antibodies | 100 ug | |||
| PLDH41-M | Mouse Anti-parasite specific lactate dehydrogenase (pLDH), (P. knowlesi) IgG | Antibodies | 100 ug | |||
| PPPP312-P | (PPPPNPPND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP), pure | Peptides pure | 1 mg | |||
| SAGF11-M | Mouse Anti-S Antigen (Sag) (P. falciparum) IgG, aff pure #1 | Antibodies | 100 ug | |||
| SAGF12-M | Mouse Anti-S Antigen (Sag) (P. falciparum) IgG, aff pure #2 | Antibodies | 100 ug | |||
| SP-88357-1 | MSP-1 (20 - 39), Merozoite Surface Peptide 1 (AA:Val-Thr-His-Glu-Ser-Tyr-Gln-Glu-Leu-Val-Lys-Lys-Leu-Glu-Ala-Leu-Glu-Asp-Ala-Val) (MW: 2301.60) | Pure Peptide | 1 mg | |||
| 970-400-CUX | Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Malaria Proteins (CSP/MSP-1/MSP-2/DBL5/VAR2CSA) by ELISA | ELISA Kit | custom | |||
| MSPF11-C | Recombinant (E. coli) merozoite surface protein-1 (MSP-1; P. falciparum) protein control for Western | Western control | 100 ul | |||
